CPVT

FAMILION LQTS, CPVT and DCM panels is also a strong indication of the speed at which genetic discovery and validation of these markers is taking place, and PGxHealth's leadership and ability to bring these innovations to patients.

Clinical Data, Inc. Launches FAMILION® Genetic Tests for Left Ventricular Noncompaction and Long QT Syndrome Large Deletion/Duplication Mutations - Yahoo! Finance 2010

"Calcium is released from the stores into the heart cells through specific channels and we have found that Flecainide reduces the ability of these channels to release calcium, thereby directly counteracting the cause of CPVT."

Medindia Health News 2009

Associate Professor Derek Laver from the University of Newcastle and international colleagues have found that Flecainide - a drug used to treat heart arrhythmias - could also be used to treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

unknown title 2009

Entech uses its proprietary concentrating photovoltaic and thermal (CPVT) technology to deliver the ThermaVolt ™ system, which produces cost-competitive distributed energy.

Renewable Energy News - RenewableEnergyWorld.com 2009

Associate Professor Laver said CPVT was caused by too much calcium being released from calcium stores within the heart cells.

unknown title 2009

Flecainide, a common drug used for arrhythmias patients could treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), a rare inherited heart disorder,

Medindia Health News 2009

Associate Professor Laver said CPVT was caused by too much calcium being released from calcium stores within the heart cells.

Medindia Health News 2009

Currently, beta-blockers are used to treat CPVT but 37 per cent of patients are unresponsive and 24 per cent suffer sudden cardiac death within 10 years of beginning treatment.

unknown title 2009

Currently, beta-blockers are used to treat CPVT but 37 per cent of patients are unresponsive and 24 per cent suffer sudden cardiac death within 10 years of beginning treatment.

Medindia Health News 2009

"Calcium is released from the stores into the heart cells through specific channels and we have found that Flecainide reduces the ability of these channels to release calcium, thereby directly counteracting the cause of CPVT."

unknown title 2009